PRESS RELEASE
News
-
-
PRESS RELEASE
US Nuclear's Medical Isotope Production to Revolutionize Healthcare
US Nuclear Corp announces plan to bring medical isotopes to the market, reshaping healthcare with revolutionary isotope production through clean fusion power. The shortage of medical isotopes, critical for precise diagnostics, will be addressed, potentially doubling the $10 billion market and providing access to advanced care worldwide -
PRESS RELEASE
Update on the Respiratory Disease Clinical Study at the University of Alberta's Faculty of Medicine & Dentistry, Powered by AI/ML Innovations' AI-driven, Patented Smart Sensor Technology
Health Gauge Inc. shares an update on the 'Electronic Patient Reported Biometric Measures' (ePReBMs) clinical study, highlighting the use of AI/ML Innovations' 'The Pulse Whisperer' patented technology in collaboration with the University of Alberta. Recruitment is underway for the trial to monitor patients with respiratory diseases using the Phoenix wrist wearable -
PRESS RELEASE
Swan Global Investments Partners with O’Shares Investments to Launch Innovative Approach to Income Generation
Swan Global Investments and O'Shares Investments join forces to launch the Swan Enhanced Dividend Income Strategy, combining options expertise and index development for regular income and capital appreciation -
PRESS RELEASE
Jochen Schweizer Showacts Presents Spectacular LED Light & Air Percussion Show at the World's Largest IT Expo 'GITEX' in Dubai
Etisalat showcased groundbreaking technologies and collaboration with Jochen Schweizer at GITEX 2023, setting a benchmark for innovation in the telecommunications industry -
-
PRESS RELEASE
Market Logic Software and Nextatlas Announce Partnership to Enhance AI-Driven Market Insights
Market Logic Software partners with Nextatlas, integrating AI-driven trend forecasting and consumer insights to revolutionize business decision-making and innovation. The partnership streamlines the process for enterprises to access and share fresh insights across their organizations -
-
PRESS RELEASE
Zentek Announces Positive Therapeutic Results achieved by Triera Biosciences for C19HBA
Zentek Ltd.'s subsidiary Triera Biosciences completes successful testing of C19HBA aptamer as therapeutic for SARS-CoV-2, outperforming monoclonal antibody in preclinical trials. C19HBA shows potential for prophylaxis and treatment. Future clinical trials and partnerships to be pursued -
